Get PSM's Weekly Counterfeit Medicine News Roundup
Importation news
Learn about Canadian drug importation; about Federal or state implementation in Colorado, Connecticut, Florida, Maine, New Hampshire, New Mexico, Texas, or Vermont; or check the progress of bills in state legislatures.
Take action!
Ask your Senator to make fentanyl analogues controlled substances
Contact your legislators to stop fake online pharmacies and report social media drug sellers to the DEA
Follow us: Twitter | YouTube | Facebook | LinkedIn | Instagram
Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, will participate in the upcoming United States Patent and Trademark Office Roundtable: Future strategies in anti-counterfeiting and anti-piracy.
USFDA is concerned that eight companies, including two pharmacies, are illegally marketing unapproved ophthalmic drug products that pose a heightened risk to users. Counterfeit pills make the DHS’ threat assessment list for 2024.
Data recently shared in the Morbidity and Mortality Weekly Report highlights a growing problem: Counterfeit pill availability is rising in the drug supply chain, but also the illicit drug market.
Running slides between conference sessions and during breaks is a great way to fit in a little extra information. Use these slides to teach your community about counterfeit medicines in the U.S.
Watch our February 2023 Congressional Briefing:
- Highlights
- The whole event, with remarks by Senator Rick Scott.
- Our virtual briefing, with even more information.
Videos
Fake prescription drugs in Mexico are also a threat to Americans. Learn why.
What happened to a Scottish woman who used black market Saxenda?
Preview NABP's online DSCSA tool.
Like our videos? Subscribe to our YouTube playlist for more!